Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Powder Keg

Not trying to burst any bubbles here, but I thought it instructive to take a look at the price action before and following the previous Markman hearing in June 2007:

1st June 2007 - closed 0.51 (seems a long time ago, eh?)

15th June 2007 - closed 0.45

Markman Judgement published - deemed generally favourable towards PTSC/TPL case.

18th June 2007 - closed 0.58 (intra-day high 0.63) on 8M shares traded

25th June 2007 - closed 0.59

15th July 2007 - one month after Markman - closed 0.51

With the exception of June 18, volume never rose above 2M shares/day in the month following the Markman judgement.

If the current Markman outcome was published tomorrow, with the same percentage changes applied to todays closing (0.16), we could expect a Friday close of about 0.21, pps topping out at 0.22 by next Friday, and a drop back to 0.16 by April 1st.

My point here is not to make price predictions or rain on anyone's parade. My point is that revenues result in pps appreciation, and that consistent revenues result in consistent pps appreciation. The rest is largely background noise, and whilst causing much breathless blogosphere glee , is essentally irrelevant.

My only exception to this would be if the BOD were summarily removed and replaced by competents, which would result in stratospheric price increases on unimaginable volume...in my opinion :)

Share
New Message
Please login to post a reply